Highly Efficient Site-Specific Mutagenesis in Malaria Mosquitoes Using CRISPR.

Abstract

Anopheles mosquitoes transmit at least 200 million annual malaria infections worldwide. Despite considerable genomic resources, mechanistic understanding of biological processes in Anopheles has been hampered by a lack of tools for reverse genetics. Here, we report successful application of the CRISPR/Cas9 system for highly efficient, site-specific mutagenesis in the diverse malaria vectors Anopheles albimanus , A. coluzzii , and A. funestus When guide RNAs (gRNAs) and Cas9 protein are injected at high concentration, germline mutations are common and usually biallelic, allowing for the rapid creation of stable mutant lines for reverse genetic analysis. Our protocol should enable researchers to dissect the molecular and cellular basis of anopheline traits critical to successful disease transmission, potentially exposing new targets for malaria control.

Evidence profile

Study type

laboratory

Text reviewed by the copilot

Full text is available

Publication status

published

Corrections or retractions

none

Conflict statement

Not supplied in the PubMed record

Topics and methods

Ask about this paper